Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 22F. Hoffmann-La Roche

02 6Roche Diagnostics GmbH

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Trastuzumab Emtansine

Brand Name : Kadcyla

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 100mg

Packaging :

Approval Date : 02/05/2013

Application Number : 62892

Regulatory Info : Allowed

Registration Country : Switzerland

blank

02

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Trastuzumab Emtansine

Brand Name : Kadcyla

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 160mg

Packaging :

Approval Date : 02/05/2013

Application Number : 62892

Regulatory Info : Allowed

Registration Country : Switzerland

blank

03

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Trastuzumabemtansin

Brand Name : Kadcyla

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 100mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

04

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Trastuzumabemtansin

Brand Name : Kadcyla

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 160mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

05

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Trastuzumab emtansine

Brand Name : Kadcyla

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 100mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

06

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Trastuzumab emtansine

Brand Name : Kadcyla

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 160mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

07

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Trastuzumab Emtansine

Brand Name : Kadcyla

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 100mg

Packaging :

Approval Date : 15-11-2013

Application Number : 28105143712

Regulatory Info : Prescription

Registration Country : Denmark

blank

08

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Trastuzumab Emtansine

Brand Name : Kadcyla

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 160mg

Packaging :

Approval Date : 15-11-2013

Application Number : 28105143812

Regulatory Info : Prescription

Registration Country : Denmark

blank

09

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Trastuzumab Emtansine

Brand Name : Kadcyla

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 100mg

Packaging :

Approval Date : 15-11-2013

Application Number : 2.01E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

10

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Trastuzumab Emtansine

Brand Name : Kadcyla

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 160mg

Packaging :

Approval Date : 15-11-2013

Application Number : 2.01E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

11

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

TRASTUZUMAB EMTANSINE

Brand Name : KADCYLA

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 100MG/VIAL

Packaging : 15ML/20ML

Approval Date :

Application Number : 2412365

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

12

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

TRASTUZUMAB EMTANSINE

Brand Name : KADCYLA

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 160MG/VIAL

Packaging :

Approval Date :

Application Number : 2473224

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

13

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Trastuzumab Emtansine

Brand Name : Kadcyla 100

Dosage Form : INF

Dosage Strength : 100mg

Packaging : 5X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

14

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Trastuzumab Emtansine

Brand Name : Kadcyla 160

Dosage Form : INF

Dosage Strength : 160mg

Packaging : 8X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

15

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Trastuzumab Emtansine

Brand Name : Kadcyla

Dosage Form : Powder For Concentrate For Infusion Solution

Dosage Strength : 100MG

Packaging :

Approval Date : 26-12-2013

Application Number : 113885001

Regulatory Info : Authorized

Registration Country : Spain

blank

16

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Trastuzumab Emtansine

Brand Name : Kadcyla

Dosage Form : Powder For Concentrate For Infusion Solution

Dosage Strength : 160MG

Packaging :

Approval Date : 03-11-2020

Application Number : 113885002IP

Regulatory Info : Authorized

Registration Country : Spain

blank

17

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Trastuzumab Emtansine

Brand Name : Kadcyla

Dosage Form : Powder For Concentrate For Infusion Solution

Dosage Strength : 100MG

Packaging :

Approval Date : 22-05-2024

Application Number : 113885001IP1

Regulatory Info : Authorized

Registration Country : Spain

blank

18

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Trastuzumab Emtansine

Brand Name : Kadcyla

Dosage Form : Powder For Concentrate For Infusion Solution

Dosage Strength : 160MG

Packaging :

Approval Date : 22-05-2024

Application Number : 113885002IP1

Regulatory Info : Authorized

Registration Country : Spain

blank

19

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Trastuzumab Emtansine

Brand Name : Kadcyla

Dosage Form : Powder For Concentrate For Infusion Solution

Dosage Strength : 160MG

Packaging :

Approval Date : 26-12-2013

Application Number : 113885002

Regulatory Info : Authorized

Registration Country : Spain

blank

20

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Trastuzumab Emtansine

Brand Name : Kadcyla

Dosage Form : Powder For Concentrate For Infusion Solution

Dosage Strength : 100MG

Packaging :

Approval Date : 03-11-2020

Application Number : 113885001IP

Regulatory Info : Authorized

Registration Country : Spain

blank